ALK and non-small cell lung carcinoma: Interestingly, the worse outcome of smoker ALK+ and EGFR+ NSCLC patients [2, 6] appears to correlate with a higher TMB [51], which illustrates again how “traditional” clinical risk factors can be redefined at the molecular level in order to promote deeper understanding of basic pathogenetic processes.